Sector Insight: What Is Driving HME DME & Home Health M&A Transactions in 2026/2027?
What Are Buyers and Investors Looking For In Acquisitions
The M&A outlook for HME businesses is strong with increased buyer demand for well-prepared, technology-enabled Providers. Buyer appetite for home medical equipment businesses is strong, but it is quite selective. Our recent sale of New Hampshire Medical Supply, a platform HME business acquired by American Wellness Group, is a good example of what buyers want: scaled, profitable, technology driven, well-run providers with strong management teams.
What is driving activity include regional and national providers as they strategically grow market share in their market areas. Large, diversified suppliers such as Medline, McKesson, Cardinal, and Accendra are building or expanding into “direct-to-home” offerings. Also, some product manufacturers are also launching their own “direct-to-patient” networks with contracted third-party reimbursement models. The HME sector lines continue to blur, as some providers are also converging with in-home healthcare, pharmacy/infusion, diagnostics, and telemedicine… and the buyer appetite is expanding with them.
The return of competitive bidding will affect providers in some of the targeted categories, especially those heavily dependent on Medicare and other government programs. Past bidding rounds ultimately produced larger, more focused businesses, often with lower but more stable margins. Time will again prove this out.
It should be noted that the “Mom-and-Pop” providers are not dead, but they have indeed evolved. The strongest independent operators have invested in technology, compliance, reimbursement management, and scalable operations. Many are professionally managed businesses with experienced leadership and disciplined processes, and they make attractive acquisition targets. Buyers and investors are paying the most for established, profitable companies, generally those with more than $10 million in annual revenue.
The alternative is harder to sell. Providers with outdated operating models, questionable regulatory compliance, narrow product lines, or stagnant referral relationships tend to see flat revenue, shrinking profitability, and rising competitive pressure. In this market, standing still means falling behind.
Demand is exceptionally strong for well-managed, profitable, technology-enabled businesses with:
- Scalable, regulatory compliant operations
- Diversified referral sources
- Recurring annual revenue > $10MM
- Consistent, reliable financial reporting
- Leadership – a strong, committed management team
Many transactions aim to build integrated home-based care platforms that use automation, Ai/Si, analytics, and digital patient engagement to improve outcomes and efficiency. Companies with strong infrastructure, compliance, technology, and management talent command the most interest and the best valuations. Buyers are often looking for expanded density in key market areas.
We are highly optimistic about M&A markets for HME and home healthcare businesses as we go into 2027. Favorable demographics, the continued shift of care into the home, abundant private equity capital, and acquisitive strategic buyers all support the demand. The continued growth of direct-to-patient models, a trend we anticipated years ago, should keep deal activity robust as providers, payers, manufacturers, distributors, and technology companies integrate. But a premium valuation takes more than a successful business. It takes realistic expectations and a well-executed process.
Billions in acquisition capital are available, but buyers are conducting deeper financial, operational, legal, regulatory, cybersecurity, reimbursement, and compliance diligence than ever before. The best outcomes go to owners who prepare well before going to market. A few key metrics include:
- A Quality of Earnings (QoE) review. It builds buyer confidence, surfaces issues before diligence does, supports valuation, and improves the odds of closing.
- Keep financial reporting clean and defensible.
- Document compliance programs thoroughly.
- Organize contracts and validate operating metrics.
- Prepare management to respond quickly throughout diligence.
- Don’t go it alone. A sector-experienced M&A advisory will deliver results well in excess of any fees they may charge.
Preparation is now a competitive advantage. Owners who address diligence requirements early protect their valuation and improve deal certainty.
For more information on the current market opportunities for your business, contact Paragon Ventures – email: partners@paragonventures.com or click here or call us at 800-719-1555.
